OpenAlex
PricingAboutJobs
Log inGet started
Work

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double‐blind, methotrexate‐controlled study of patients with active rheumatoid arthritis

HTML

Year: 2009
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Arthritis & Rheumatism
DOI: 10.1002/art.24266
Authors: Stanley B. Cohen, Tien‐Tsai Cheng, Vishala Chindalore, Nemanja Damjanov, Ruben Burgos‐Vargas, Patricia DeLora, Kathleen Zimany, Helen Travers, John P. Caulfield
Institutions: Metroplex Clinical Research Center, Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, University of Belgrade, Institut za Reumatologiju, Hospital General de México, Roche (United Kingdom)
Language: English

Topic: Rheumatoid Arthritis Research and Therapies
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: p38 MAP kinase inhibitors, rheumatoid arthritis, methotrexate, monotherapy, ACR20 response, DAS28, drug safety, adverse events, dose-dependent toxicity, immunosuppression
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2132049460
FWCI: 18.09
Cites: 28
Cited by: 245
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms